BPH NCLEX 2026 STUDY GUIDE COMPLETE
BENIGN PROSTATIC HYPERPLASIA CONCEPTS
AND NURSING CARE PRACTICE QUESTIONS
◉ Difficulty starting urination. Answer: A classic symptom of BPH
caused by prostate enlargement obstructing the urethra.
◉ Nocturia. Answer: Caused by incomplete bladder emptying,
leading to frequent nighttime urination.
◉ Alpha-adrenergic blockers. Answer: Medications that relax
smooth muscles in the prostate and bladder neck, improving urinary
flow.
◉ Dietary modification for BPH. Answer: Avoiding caffeine and
alcohol, as they can irritate the bladder and worsen symptoms.
◉ Digital rectal exam (DRE). Answer: Used to evaluate the size,
symmetry, and texture of the prostate.
◉ Uroflowmetry. Answer: Typically shows a reduced urine flow rate
due to obstruction of the urethra in clients with BPH.
, ◉ Prostate-specific antigen (PSA). Answer: A diagnostic study that
helps rule out prostate cancer in a client with BPH.
◉ Postvoid residual (PVR) urine volume. Answer: A PVR >100 mL
indicates significant urinary retention, often caused by obstruction.
◉ Blood urea nitrogen (BUN) and creatinine. Answer: Lab results
monitored to detect kidney complications in a client with BPH.
◉ Tamsulosin. Answer: A medication most appropriate for a client
experiencing moderate symptoms of BPH.
◉ Finasteride. Answer: A medication used in the management of
BPH, though not specified for moderate symptoms.
◉ Levofloxacin. Answer: An antibiotic that is not specifically
indicated for BPH management.
◉ Oxybutynin. Answer: A medication that is not specifically
indicated for BPH management.
◉ Signs of infection. Answer: Symptoms that may need assessment
in clients with BPH but are not the priority.
BENIGN PROSTATIC HYPERPLASIA CONCEPTS
AND NURSING CARE PRACTICE QUESTIONS
◉ Difficulty starting urination. Answer: A classic symptom of BPH
caused by prostate enlargement obstructing the urethra.
◉ Nocturia. Answer: Caused by incomplete bladder emptying,
leading to frequent nighttime urination.
◉ Alpha-adrenergic blockers. Answer: Medications that relax
smooth muscles in the prostate and bladder neck, improving urinary
flow.
◉ Dietary modification for BPH. Answer: Avoiding caffeine and
alcohol, as they can irritate the bladder and worsen symptoms.
◉ Digital rectal exam (DRE). Answer: Used to evaluate the size,
symmetry, and texture of the prostate.
◉ Uroflowmetry. Answer: Typically shows a reduced urine flow rate
due to obstruction of the urethra in clients with BPH.
, ◉ Prostate-specific antigen (PSA). Answer: A diagnostic study that
helps rule out prostate cancer in a client with BPH.
◉ Postvoid residual (PVR) urine volume. Answer: A PVR >100 mL
indicates significant urinary retention, often caused by obstruction.
◉ Blood urea nitrogen (BUN) and creatinine. Answer: Lab results
monitored to detect kidney complications in a client with BPH.
◉ Tamsulosin. Answer: A medication most appropriate for a client
experiencing moderate symptoms of BPH.
◉ Finasteride. Answer: A medication used in the management of
BPH, though not specified for moderate symptoms.
◉ Levofloxacin. Answer: An antibiotic that is not specifically
indicated for BPH management.
◉ Oxybutynin. Answer: A medication that is not specifically
indicated for BPH management.
◉ Signs of infection. Answer: Symptoms that may need assessment
in clients with BPH but are not the priority.
